Clinical Trial RESULTS
How many participants had serious medical problems?
A medical problem is considered serious when it causes death, is life-threatening,
causes lasting problems, causes birth defects, needs hospital care, or is considered
an important medical event. In this study, participants had serious medical problems
that either needed hospital care or was considered important by a participantâ€™s
doctor. No participants died in this study.
The number of participants who had serious medical problems in this study was
about the same in each treatment group. The table below shows the serious medical
problems that happened to more than one participant in the study. All the other
serious medical problems happened to single participants. Doctors did not think any
of the serious medical problems were related to the study drug.
10 mg of Ticagrelor 45 mg of Ticagrelor Placebo
(Out of 26 (Out of 30 (Out of 30
Serious medical problem participants) participants) participants)
Sickle cell anemia with
crisis (sickle cell disease- 5 (19.2%) 3 (10.0%) 3 (10.0%)
related attack)
Stomach flu 0 (0.0%) 1 (3.3%) 2 (6.7%)
Acute chest syndrome
(sickle cell disease-related 1 (3.8%) 1 (3.3%) 0 (0.0%)
lung condition)
What were the most common medical problems in the study?
Headache was the most common medical problem in this study. The table below
shows the most common medical problems that happened to at least four
participants in any treatment group.
10 mg of Ticagrelor 45 mg of Ticagrelor Placebo
(Out of 26 (Out of 30 (Out of 30
Common medical problem participants) participants) participants)
Headache 11 (42.3%) 8 (26.7%) 8 (26.7%)
Joint pain 6 (23.1%) 9 (30.0%) 6 (20.0%)
Sickle cell anemia with
crisis (sickle cell disease- 5 (19.2%) 5 (16.7%) 3 (10.0%)
related attack)
Belly pain 5 (19.2%) 3 (10.0%) 3 (10.0%)
Back pain 4 (15.4%) 4 (13.3%) 8 (26.7%)
Pain in arms, hands, legs,
4 (15.4%) 9 (30.0%) 5 (16.7%)
or feet
7